“Comparison of Study Designs for Primary Phase III Trials for Omalizumab Versus Dupilumab for Patients With Chronic Spontaneous Urticaria”. 2024. SKIN The Journal of Cutaneous Medicine 8 (1): s333. https://doi.org/10.25251/skin.8.supp.333.